| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |